Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of iPS Cell Generation From Patients With COPD

NCT01860898 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01860898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01860898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of iPS Cell Generation From Patients With COPD
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2009
Completion date
October 28, 2014
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of lung, cancer of the lung, carcinoma, non-small-cell lung, carcinoma, small cell, copd, lung cancer, lung diseases, obstructive, neoplasms, lung, neoplasms, pulmonary, pulmonary cancer, pulmonary emphysema, pulmonary neoplasms, respiratory tract diseases, thoracic diseases